Prognostic validity of a clinical trunk control test for independence and walking in individuals with spinal cord injury

• Published in: The journal of spinal cord medicine 2020-05, Vol.43 (3), p.331-338
• Main Authors: Quinzaños-Fresnedo, Jimena, Fratini-Escobar, Paola C., Almaguer-Benavides, Kievka M., Aguirre-Güemez, Ana Valeria, Barrera-Ortíz, Aída, Pérez-Zavala, Ramiro, Villa-Romero, Antonio Rafael
• Format: Article
• Language: English
• Subjects: Prognosis; Spinal cord injuries; Trunk control
• ISSN: 1079-0268; 2045-7723
• DOI: 10.1080/10790268.2018.1518124

Objective: The objective of the present work was to determine the prognostic validity of the trunk control test for walking and independence in individuals with SCI. Design: A cohort, prospective study was carried out in all individuals with sub-acute SCI. Setting: All inpatients at the Mexico City based National Rehabilitation Institute (INR). Participants: Ninety individuals with a clinical diagnosis of sub-acute SCI, American Spinal Injury Association Impairment Scale (AIS) A-D, and that have not participated in a rehabilitation program were included. Thirty-five individuals had good initial trunk control and the remaining 55 had poor trunk control. All individuals participated in a standard rehabilitation program subsequently. Interventions: N/A Outcome Measures: The trunk control test was performed at baseline. At 1, 3, 6, 9 and 12 months after the first evaluation, walking and independence were assessed. Results: Survival Analysis revealed that 62.5% and 100% individuals with good trunk control at baseline assessment were respectively walking and independent in ADL at 12 months and 14% and 48% individuals with poor trunk control were walking and independent in ADL. Cox regression analysis revealed that individuals with good trunk control were 4.6 times more likely to walk independently at 12 months and 2.9 times more likely to be independent in activities of daily living. Conclusion: The present study revealed that the trunk control test is useful for providing a prognosis of independence and walking at 1 year in individuals with SCI, independently of the neurologic level and the severity of the injury.